About ARCTOS medical
ARCTOS medical is a Healthcare company based in Bern (Switzerland) founded in 2018, and was acquired by Novartis in September 2021. Optogenetic therapies for retinal degenerative diseases are developed. Its focus areas include Life Sciences, Ophthalmology, Drugs and Retinal Disorders.
Company details
ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.
- Headquarters Bern, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website arctosmedical.com
- Acquired by Novartis (Sep 2021)
Investors in ARCTOS medical
ARCTOS medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
R&D focused on manufacturing of drugs for multiple therapeutic areas | 1996 | novartis.com | Basel, Switzerland |
Investor details for ARCTOS medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ARCTOS medical
2 dated milestones of ARCTOS medical across 3 years, from founding to its latest funding, stage changes and deals.
- Founded ARCTOS medical is founded.
- Exit Acquired by Novartis.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ARCTOS medical
ARCTOS medical was founded in 2018.
ARCTOS medical is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.
ARCTOS medical has 1 investor. Key investors include Novartis.
Yes. ARCTOS medical was acquired by Novartis in September 2021.
